Steven M Paul Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

Steven M Paul is of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 10,596 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $3,496,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

STEVEN M PAUL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Sale (or disposition) back to the issuer
$3,496,680 $330.0 p/Share
10,596 Reduced 100.0%
0 Common Stock
Feb 23 2024
BUY
Exercise of conversion of derivative security
$1,686,213 $53.5 p/Share
31,518 Added 42.8%
42,114 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$254,980 $317.14 p/Share
804 Reduced 7.05%
10,596 Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
11,400 Added 50.0%
11,400 Common Stock

Also insider at

ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
Director
SAGE
Sage Therapeutics, Inc. Healthcare
VYGR
Voyager Therapeutics, Inc. Healthcare
Director
SMP

Steven M Paul

Cambridge, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX